Stryker (SYK) Total Non-Current Liabilities (2009 - 2026)
Stryker (SYK) reported Total Non-Current Liabilities of $20.9 billion for Q1 2026, down 15.23% year-over-year from $24.7 billion in Q1 2025, and down 16.31% quarter-over-quarter from $25.0 billion in Q4 2025.
Stryker (SYK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Total Non-Current Liabilities data on file, last reported at $20.9 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $20.9 billion, down 15.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.9 billion (down 15.23% YoY), and the FY2025 annual result was $25.0 billion, up 24.16% from the prior year.
- Total Non-Current Liabilities retreated to $20.9 billion in Q1 2026 per SYK's latest filing, from $25.0 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $25.0 billion in Q4 2025 and troughed at $17.4 billion in Q2 2024.
- A 5-year average of $20.5 billion and a median of $19.7 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities surged 42.19% in 2025, then dropped 15.23% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $19.6 billion in 2022, then retreated by 1.21% to $19.4 billion in 2023, then grew by 3.94% to $20.2 billion in 2024, then advanced by 24.16% to $25.0 billion in 2025, then slipped by 16.31% to $20.9 billion in 2026.
- Business Quant data shows SYK's Total Non-Current Liabilities at $20.9 billion in Q1 2026, $25.0 billion in Q4 2025, and $22.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 9.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.94 Bn |
| Dec 31, 2025 | 25.02 Bn |
| Sep 30, 2025 | 22.66 Bn |
| Jun 30, 2025 | 24.75 Bn |
| Mar 31, 2025 | 24.70 Bn |
| Dec 31, 2024 | 20.15 Bn |
| Sep 30, 2024 | 21.36 Bn |
| Jun 30, 2024 | 17.40 Bn |
| Mar 31, 2024 | 19.67 Bn |
| Dec 31, 2023 | 19.39 Bn |
| Sep 30, 2023 | 18.31 Bn |
| Jun 30, 2023 | 18.20 Bn |
| Mar 31, 2023 | 19.31 Bn |
| Dec 31, 2022 | 19.63 Bn |
| Sep 30, 2022 | 17.94 Bn |
| Jun 30, 2022 | 18.57 Bn |
| Mar 31, 2022 | 20.17 Bn |
| Dec 31, 2021 | 18.84 Bn |
| Sep 30, 2021 | 18.01 Bn |
| Jun 30, 2021 | 17.91 Bn |